A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis

被引:22
作者
Madamanchi, NR [1 ]
Hu, ZY [1 ]
Li, FZ [1 ]
Horaist, C [1 ]
Moon, SK [1 ]
Patterson, C [1 ]
Runge, MS [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 2002年 / 1576卷 / 03期
关键词
atherosclerosis; vascular development; gene regulation; transgenic mouse;
D O I
10.1016/S0167-4781(02)00308-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the human protease-activated receptor-1 (PAR-1) by thrombin leads to myriad functions essential for maintaining vascular integrity. Upregulation of PAR-1 expression is considered important in atherosclerosis, angiogenesis and tumor metastasis. In vitro analysis of the human PAR-1 promoter function revealed a positive regulatory element between -4.2 and -3.2 kb of the transcription start site. This element was examined in transgenic mice containing either 4.1 or 2.9 kb of the 5' flanking sequence driving a LacZ reporter gene. Only the 4.1 kb PAR-1 transgene was expressed in vivo and only during embryonic development. The transgene expression was observed only in developing arteries and not in veins. Further examination of this putative regulatory sequence identified a novel noncoding RNA (ncR-uPAR:noncoding RNA upstream of the PAR-1) gene at -3.4 kb. The ncR-uPAR upregulated PAR-1-core promoter-driven luciferase activity and mRNA expression in vitro in a Pol II-dependent manner. This noncoding RNA appears to act in trans, albeit locally at the adjacent PAR-1 promoter. These data suggest that an untranslated RNA plays a role in PAR-1 gene expression during embryonic growth. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:237 / 245
页数:9
相关论文
共 68 条
[1]  
[Anonymous], 1994, MANIPULATING MOUSE E
[2]  
Askew DS, 1999, HISTOL HISTOPATHOL, V14, P235, DOI 10.14670/HH-14.235
[3]  
BERK BC, 1990, J BIOL CHEM, V265, P17334
[4]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[5]   ENHANCEMENT OF INCISIONAL WOUND-HEALING AND NEOVASCULARIZATION IN NORMAL RATS BY THROMBIN AND SYNTHETIC THROMBIN RECEPTOR-ACTIVATING PEPTIDES [J].
CARNEY, DH ;
MANN, R ;
REDIN, WR ;
PERNIA, SD ;
BERRY, D ;
HEGGERS, JP ;
HAYWARD, PG ;
ROBSON, MC ;
CHRISTIE, J ;
ANNABLE, C ;
FENTON, JW ;
GLENN, KC .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1469-1477
[6]  
COLOTTA F, 1994, AM J PATHOL, V144, P975
[7]   Role of the thrombin receptor In development and evidence for a second receptor [J].
Connolly, AJ ;
Ishihara, H ;
Kahn, ML ;
Farese, RV ;
Coughlin, SR .
NATURE, 1996, 381 (6582) :516-519
[8]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[9]  
Cui HM, 1997, CANCER RES, V57, P4469
[10]  
Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860